The Role of CDK 4/6 Inhibitors in Advanced Breast Cancer

The Role of CDK 4/6 Inhibitors in Advanced Breast Cancer

User Photo
obr

1 year
64 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Debra Patt, MD, Executive Vice President, Strategic Initiatives, Academic Programs, Texas Oncology explains the role of CDK 4/6 inhibitors in advanced breast cancer and discusses whether they are interchangeable in treatment planning for patients.
Up Next Autoplay